Related Experiment Videos
Liver transplantation for factor VII deficiency.
1Department of Surgery, University of Miami/Jackson Memorial Medical Center, FL, USA.
Transplantation
|December 12, 2001
Summary
Factor VII deficiency, a severe bleeding disorder, can be effectively treated with liver transplantation. This procedure resolved severe hemorrhagic complications in two sisters, restoring normal blood coagulation.
Area of Science:
- Hematology
- Hepatology
- Transplantation
Background:
- Factor VII deficiency is a rare inherited bleeding disorder.
- It results from impaired synthesis of coagulation Factor VII in the liver.
- Severe deficiency can lead to life-threatening hemorrhage.
Observation:
- Two sisters presented with severe, recurrent bleeding episodes due to Factor VII deficiency.
- Both patients underwent successful orthotopic liver transplantation.
- Post-transplant follow-up showed resolution of hemorrhagic complications.
Findings:
- Orthotopic liver transplantation normalized Factor VII levels in both patients.
- Coagulation profiles returned to normal ranges after transplantation.
- Patients remained symptom-free with no further bleeding events.
Implications:
- Liver transplantation is a viable and curative treatment for severe Factor VII deficiency.
- This approach offers a long-term solution for patients with life-threatening bleeding.
- Successful transplantation highlights the liver's crucial role in synthesizing coagulation factors.